Htr2a Gene and 5-HT(2A) Receptor Expression in the Cerebral Cortex Studied Using Genetically Modified Mice.
Serotonin receptors of the 5-HT(2A) subtype are robustly expressed in the cerebral cortex where they have been implicated in the pathophysiology and therapeutics of mental disorders and the actions of hallucinogens. Much less is known, however, about the specific cell types expressing 5-HT(2A) receptors in cortex. In the current study we use immunohistochemical and electrophysiological approaches in genetically modified mice to address the expression of the Htr2a gene and 5-HT(2A) receptors in cortex. We first use an EGFP-expressing BAC transgenic mice and identify three main Htr2A gene expressing neuronal populations in cortex. The largest of these cell populations corresponds to layer V pyramidal cells of the anterior cortex, followed by GABAergic interneurons of the middle layers, and non-pyramidal cells of the subplate/Layer VIb. We then use 5-HT(2A) receptor knockout mice to identify an antibody capable of localizing 5-HT(2A) receptors in brain and use it to map these receptors. We find strong laminar expression of 5-HT(2A) receptors in cortex, especially along a diffuse band overlaying layer Va. This band exhibits a strong anteroposterior gradient that closely matches the localization of Htr2A expressing pyramidal cells of layer V. Finally we use electrophysiological and immunohistochemical approaches to show that most, but not all, GABAergic interneurons of the middle layers are parvalbumin expressing Fast-spiking interneurons and that these cells are depolarized and excited by serotonin, most likely through the activation of 5-HT(2A) receptors. These results clarify and extend our understanding of the cellular distribution of 5-HT(2A) receptors in the cerebral cortex.
Weber
Elaine T
ET
Department of Pharmacology, Wayne State University School of Medicine Detroit, MI, USA.
Andrade
Rodrigo
R
Neuroscience. 2003;116(1):107-17
12535944
Curr Opin Neurobiol. 2007 Aug;17(4):408-16
17702566
J Neurosci. 2009 Jun 3;29(22):7124-36
19494135
Front Neurosci. 2009 Dec 15;3(3):337-43
20198150
Mol Psychiatry. 2007 Oct;12(10):904-22
17667958
Cereb Cortex. 1997 Sep;7(6):476-86
9276173
J Comp Neurol. 2004 May 10;472(4):496-511
15065122
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):735-40
9435262
J Neurophysiol. 1999 Dec;82(6):2989-99
10601434
J Neurosci. 2001 Dec 15;21(24):9856-66
11739593
J Pharmacol Exp Ther. 1998 May;285(2):805-12
9580630
J Neurosci Methods. 1997 Nov 7;77(1):109-17
9402563
J Neurosci. 2003 Apr 15;23(8):3373-84
12716945
J Neurochem. 2007 Oct;103(2):475-86
17635672
J Comp Neurol. 1999 Jun 28;409(2):187-209
10379914
Neuropharmacology. 1997 Apr-May;36(4-5):589-99
9225284
J Neurosci. 2004 May 19;24(20):4807-17
15152041
Neuroscience. 2007 Apr 25;146(1):306-20
17331657
Brain Res. 1986 Jun 18;376(1):97-107
2941113
J Comp Neurol. 2001 Jan 22;429(4):571-89
11135236
Brain Res Mol Brain Res. 1994 Apr;23(1-2):163-78
8028479
Nat Rev Neurosci. 2007 Jan;8(1):45-56
17180162
J Chem Neuroanat. 2001 Sep;22(3):185-203
11522440
Brain Res. 1988 Jun 21;453(1-2):315-28
3401769
Ann N Y Acad Sci. 1998 Dec 15;861:232-3
9928261
Brain Res Mol Brain Res. 1998 Mar 1;54(2):199-211
9555012
Science. 2006 Jul 28;313(5786):536-40
16873667
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9870-5
17535909
J Neurosci. 2002 Sep 15;22(18):8238-50
12223578
Brain Behav Evol. 2000 Oct;56(4):212-34
11155000
Nat Rev Neurosci. 2004 Oct;5(10):793-807
15378039
Brain Res. 1985 Nov 4;346(2):231-49
4052777
J Neurosci. 2009 Aug 12;29(32):10038-46
19675237
Neuroreport. 1998 Dec 1;9(17):3897-902
9875725
Naunyn Schmiedebergs Arch Pharmacol. 1997 Oct;356(4):446-54
9349630
Neuropharmacology. 1999 Aug;38(8):1083-152
10462127
Neuroscience. 1991;40(2):399-412
1851255
J Neurochem. 2003 Apr;85(1):1-13
12641722
Brain Res. 1990 Jul 30;524(1):139-43
2400925
Synapse. 1997 Sep;27(1):79-82
9268067
J Comp Neurol. 1995 Jan 16;351(3):357-73
7706547
Nat Rev Neurosci. 2001 Dec;2(12):861-70
11733793
Eur J Neurosci. 2005 Sep;22(5):1120-6
16176353
Nature. 2003 Oct 30;425(6961):917-25
14586460
J Neurosci. 2007 Jul 18;27(29):7786-98
17634372
J Neurosci. 2010 Feb 10;30(6):2211-22
20147548
J Histochem Cytochem. 1998 Jul;46(7):811-24
9632740
Psychopharmacol Ser. 1993;10:26-37
8361980
Nat Rev Neurosci. 2008 Jul;9(7):557-68
18568015
J Neurosci. 2008 Mar 12;28(11):2681-5
18337395
Pharmacol Rev. 1994 Jun;46(2):157-203
7938165
Neuron. 2000 Oct;28(1):41-51
11086982
Curr Med Chem. 2007;14(19):2053-69
17691947
Neuroscience. 1993 Jun;54(3):701-17
8332257
Neuroscience. 2002;111(1):163-76
11955720